Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Nov 4, 2025 · Paolini John F. sold 82.54K shares at $37.14/share ($3.1M); exercised options for 82.54K shares

Paolini John F. sold 82.54K shares at $37.14/share ($3.1M); exercised options for 82.54K shares

xslF345X05/form4-11042025_091113.xml

xslF345X05/form4-11042025_091113.xmlSEC.gov

ex24-11042025_091113.htm

ex24-11042025_091113.htmSEC.gov

Graphics and non-inline formats (not embedded below).